Holen Sie sich die Stockscreener-App
67.91
1.04%
0.70
Handel nachbörslich:
67.89
-0.02
-0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon stock holds steady as investors await fresh catalyst - AD HOC NEWS
Alcon | 7/24/26 - ktnv.com
Alcon gets you seeing in time for school - WSBT
Alcon: Back-to-School eye exams. What every parent should know. - KHGI
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India - PR Newswire
Alcon stock trades steady as eye care specialist builds on 2025 growth and higher margins - AD HOC NEWS
Systane Complete by Alcon Inc.dry eye relief built on oil-based drops - AD HOC NEWS
Alcon stock trades steadily as surgical eye care revenue grows - AD HOC NEWS
ALC stock trades steadily as Alcon lifts 2024 outlook on stronger surgical and vision care demand - Ad-hoc-news.de
Enterprise value to revenue forward of Alcon AG – SIX:ALC - TradingView
Alcon stock trades steadily as recent earnings highlight margin and growth mix - Ad-hoc-news.de
Alcon (SWX:ALC) Stock Looks Undervalued On Cash Flow But Fair On Earnings - Yahoo Finance
Alcon stock supported by steady growth and surgical demand - Ad-hoc-news.de
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35 - GuruFocus
ALC|Alcon AG|Price:67.210| - TradingKey
Alcon stock holds its ground as 2025 sales and profit metrics frame the 22 July 2026 setup - Ad-hoc-news.de
Sight Sciences wins $34M patent ruling against Alcon - MSN
The Systane Ultra Lubricant Eye Drops. Dry-eye care with a long shelf presence - Ad-hoc-news.de
Alcon stock trades steady as recent earnings highlight margin and growth dynamics - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts rising revenue and margins - Ad-hoc-news.de
Alcon stock steadies as surgical eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades steadily as surgical vision business supports earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye-care growth supports earnings - Ad-hoc-news.de
Mexican Gold Mining Corp. and Alcon Silver Corp. Complete Arrangement to Create Platauro Metals Corp., a Diversified Precious Metals Exploration Company - TMX Newsfile
Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Alcon stock trades steadily as surgical eye care growth supports earnings outlook - Ad-hoc-news.de
Price to book forward of Alcon AG – BX:2U3 - TradingView
Alcon stock trades steadily as eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades near recent highs as surgical vision demand supports growth - Ad-hoc-news.de
Alcon stock trades steadily as eye care group highlights Q1 2026 growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as eye care leader builds on solid revenue growth - Ad-hoc-news.de
Alcon stock steadies as investors weigh surgical vision growth and recent earnings trends - Ad-hoc-news.de
Alcon stock trades steady as eye-care margins support growth outlook - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports margins - ad-hoc-news.de
Systane Augentropfen by Alcon Inc.dry-eye relief built on medical data - ad-hoc-news.de
Alcon stock trades steady as vision care group focuses on margin and growth after 2025 earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports recent earnings - ad-hoc-news.de
Alcon stock trades steady as latest earnings show margin resilience - ad-hoc-news.de
Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $80 - Moomoo
Alcon stock holds steady as eye-care demand supports the long-term growth story - ad-hoc-news.de
Systane Hydration by Alcon Inc.dry eye relief beyond the pharmacy shelf - ad-hoc-news.de
Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells In - GuruFocus
Alcon: From Reactive to Proactive with Centralized Regulatory Intelligence - Veeva
Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology - Zacks Investment Research
Systane Ultra Lubricant Eye Drops by Alcon Inc.dry-eye relief drives a global franchise - ad-hoc-news.de
Ophthalmology Devices Market Report Released, Includes - GlobeNewswire
Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others - Yahoo Finance UK
Alcon stock reflects ophthalmic focus as global eye care demand grows - ad-hoc-news.de
Alcon collaborates with RxSight to develop adjustable PCIOLs - MSN
Alcon, RxSight announce collaboration to develop adjustable presbyopia-correcting IOLs - Ophthalmology Times Europe
Systane Ultra eye drops by Alcon Inc.dry-eye relief backed by a broad product family - Ad-hoc-news.de
Alcon stock holds steady as the contact lens business anchors results - ad-hoc-news.de
RxSight Q2 sales sink 20% as Alcon deal bolsters 2026 outlook - MSN
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook - TradingView
Alcon stock reflects steady growth as eye care demand expands - ad-hoc-news.de
Alcon stock reflects steady growth prospects as eye care demand expands globally - ad-hoc-news.de
Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know - Yahoo Finance
Alcon Inc focuses on eye care leadership as investors watch global demand - ad-hoc-news.de
Alcon focus on eye care growth and global market presence - AD HOC NEWS
Is Alcon (SWX:ALC) Cheap Following Its RxSight Collaboration And Premium P E? - simplywall.st
Is Alcon (SWX:ALC) Undervalued After Its RxSight Collaboration? - Yahoo Finance
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones? - Insider Monkey
Alcon Inc focuses on eye care growth and global expansion - ad-hoc-news.de
Systane Complete by Alcondry eye relief with lipid layer support - AD HOC NEWS
2.98%
7.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):